Oxawind
Brand Name: Oxawind
Generic Name: Oxaliplatin
Active
Registration Number
DRP-8699-02
Dosage Form
Solution for Injection (IV)
Issuance Date
May 31, 2023
Expiry Date
September 12, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength2mg/mL (50mg/25mL)
PackagingUSP Type I Amber Glass Vial x 30mL (Box of 1's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
OxaliplatinActive
Monograph: Oxaliplatin